Eisai
4523.T
#2184
Rank
S$10.97 B
Marketcap
S$38.90
Share price
0.11%
Change (1 day)
-0.84%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.12. an increase over its 2024 EPS that were of S$1.27.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025S$1.4211.85%
2024S$1.27-32.63%
2023S$1.885.52%
2022S$1.78-74.01%
2021S$6.86-66.58%
2020S$20.5298.24%
2019S$10.3517.01%
2018S$8.8437.78%
2017S$6.42-27.62%
2016S$8.8735.33%
2015S$6.55-2.82%
2014S$6.74-27.66%
2013S$9.32-27.49%
2012S$12.86-12.67%
2011S$14.7288.08%
2010S$7.83-11.06%
2009S$8.80-390.15%
2008S-$3.03-127.78%
2007S$10.9211.78%
2006S$9.774.38%
2005S$9.367.4%
2004S$8.7243.03%
2003S$6.1025.09%
2002S$4.8752.67%
2001S$3.1969.76%
2000S$1.88